Cargando…
Topically delivered nitric oxide acts synergistically with an orally administered PDE5 inhibitor in eliciting an erectile response in a rat model of radical prostatectomy.
Patients undergoing radical prostatectomy (RP) have a high incidence of post-operative erectile dysfunction (ED) refractory to treatment by oral phosphodiesterase-type-5-inhibitors (PDE5i). In the present studies, we investigated if a topically applied, nitric oxide microparticle delivery system (NO...
Autores principales: | Tar, Moses T., Friedman, Joel M., Draganski, Andrew, Davies, Kelvin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842897/ https://www.ncbi.nlm.nih.gov/pubmed/34017115 http://dx.doi.org/10.1038/s41443-021-00451-6 |
Ejemplares similares
-
Management of erectile dysfunction post-radical prostatectomy
por: Saleh, Alan, et al.
Publicado: (2015) -
Erectile dysfunction in robotic radical prostatectomy: Outcomes and management
por: Whelan, Patrick, et al.
Publicado: (2014) -
The paradox of erectile dysfunction data after radical prostatectomy
por: Moretti, Tomás Bernardo Costa, et al.
Publicado: (2022) -
Immediate post-operative PDE5i therapy improves early erectile function outcomes after robot assisted radical prostatectomy (RARP)
por: Nathan, Arjun, et al.
Publicado: (2021) -
Incontinence and Erectile Dysfunction Following Radical Prostatectomy: A Review
por: Alivizatos, Gerasimos, et al.
Publicado: (2005)